The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
MAP Kinase Activation by Fluoxetine and Its Relation to Gene Expression in Cultured Rat Astrocytes
Abstract
Chronic treatments with antidepressants active on major depressive disorders influence pathways involved in cell survival and plasticity. As astrocytes seem to play a key role in the protection of brain cells, we investigated in these cells the rapid effects of the antidepressant fluoxetine (Prozac) on signaling cascades and gene induction, which probably play a role in neuroprotection. We show here that fluoxetine alone activates the extracellular signal-regulated-protein kinase (Erk) and p38 mitogen-associated protein (MAP) kinase cascades. RT-PCR revealed that genes, modulated in brain by long-term fluoxetine treatment, are rapidly induced by fluoxetine in cultured astrocytes: brain-derived nerve factor (BDNF) and its receptors, glial-derived nerve factor (GDNF) and deiodinase 3 (D3). Induction of D3 by fluoxetine is inhibited by U0126 and SB203580, suggesting that Erk and p38 MAP kinases are involved. Glial-derived nerve factor (GDNF) induction by fluoxetine is prevented by U0126, suggesting that Erk is implicated. Brain-derived nerve factor (BDNF) induction seems mediated by other signaling pathways. In conclusion, we show that fluoxetine alone rapidly activates mitogen activated protein (MAP) kinase cascades in rat astrocytes and that genes involved in neuroprotection are induced in a few hours in a MAP kinase-dependent or -independent manner.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is known that MAPK1 activation is altered after stress [31] and corticosterone exposure [32] and that MAPK signaling was proposed to regulate AD modulation of glial cell line-derived neurotrophic factor [33].”
From The Impact of BDNF, NTRK2, NGFR, CREB1, GSK3B, AKT, MAPK1, MTOR, PTEN, ARC, and SYN1 Genetic Polymorphisms in Antidepressant Treatment Response Phenotypes (2023) · cites this paper as [33]
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,311
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
A molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,334
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Nibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109
STRESS AND HIPPOCAMPAL PLASTICITY
McEwen, B. S. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.105 · Cited by 2,087
Ca2+ Influx Regulates BDNF Transcription by a CREB Family Transcription Factor-Dependent Mechanism
Tao, X., Finkbeiner, S., Arnold, D. B., Shaywitz, A. J., & Greenberg, M. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)81010-7 · Cited by 1,561
Gould, E., Tanapat, P., McEwen, B. S., Flügge, G., & Fuchs, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3168 · Cited by 1,395
Control of Synapse Number by Glia
Ullian, E. M., Sapperstein, S. K., Christopherson, K. S., & Barres, B. A. (2001) · Science · doi:10.1126/science.291.5504.657 · Cited by 1,380
Flagged first, then by citations
1 of the 47 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Schmidt, H. D., & Duman, R. S. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282ee2aa8 · Cited by 662
Chen, P.-S., Peng, G.-S., Li, G., Yang, S., Wu, X., Wang, C. C., Wilson, B. C., Lu, R.-B., Gean, P.-W., Chuang, D.-M., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001893 · Cited by 356
Anisman, H., Merali, Z., & Hayley, S. P. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.004 · Cited by 341
Hayley, S., Poulter, M. O., Merali, Z., & Anisman, H. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.03.051 · Cited by 324
Rantamäki, T., Hendolin, P., Kankaanpää, A., Mijatovic, J., Piepponen, P., Domenici, E., Chao, M. V., Männistö, P. T., & Castrén, E. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301345 · Cited by 305
Tardito, D., Perez, J., Tiraboschi, E., Musazzi, L., Racagni, G., & Popoli, M. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.7 · Cited by 303
The neurodevelopmental origins of suicidal behavior
Turecki, G., Ernst, C., Jollant, F., Labonté, B., & Mechawar, N. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.008 · Cited by 299
Rao, J. S., Ertley, R. N., Lee, H.-J., DeMar, J. C., Arnold, J. T., Rapoport, S. I., & Bazinet, R. P. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001888 · Cited by 291
RetractedErnst, C., Deleva, V., Deng, X., Sequeira, A., Pomarenski, A., Klempan, T., Ernst, N., Quirion, R., Gratton, A., Szyf, M., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archpsyc.66.1.22 · Cited by 235
An astroglial basis of major depressive disorder? An overview
Wang, Q., Jie, W., Liu, J., Yang, J., & Gao, T. (2017) · Glia · doi:10.1002/glia.23143 · Cited by 222
Lu, D., Tsao, Y.-Y., Leung, Y., & Su, K. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.98 · Cited by 185
Levkovitz, Y., Gil‐Ad, I., Zeldich, E., Dayag, M., & Weizman, A. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:27:1:029 · Cited by 172
Peng, C., Chiou, S., Chen, S., Chou, Y., Ku, H., Cheng, C., Yen, C.-J., Tsai, T., Chang, Y., & Kao, C.-L. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.05.002 · Cited by 145
Neurotrophic factors (BDNF and GDNF) and the serotonergic system of the brain
Popova, N. K., Ilchibaeva, T. V., & Naumenko, V. S. (2017) · Biochemistry (Moscow) · doi:10.1134/s0006297917030099 · Cited by 146
Antidepressants act directly on astrocytes: Evidences and functional consequences
Czéh, B., & Benedetto, B. D. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.04.017 · Cited by 132
Dwivedi, Y., Rizavi, H. S., Conley, R. R., & Pandey, G. N. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001744 · Cited by 125
Hodge, J. M., Wang, Y., Berk, M., Collier, F. M., Fernandes, T. J., Constable, M. J., Pasco, J. A., Dodd, S., Nicholson, G. C., Kennedy, R. L., et al. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.11.003 · Cited by 122
The neurotrophic and neuroprotective effects of psychotropic agents
Hunsberger, J. G., Austin, D. R., Henter, I. D., & Chen, G. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.3/jhunsberger · Cited by 123
Caso, J. R., MacDowell, K. S., González-Pinto, A. M., García, S., de Diego-Adeliño, J., Carceller‐Sindreu, M., Sarramea, F., Caballero‐Villarraso, J., Gracia‐García, P., de la Cámara, C., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01755-3 · Cited by 110
Li, B., Zhang, S., Zhang, H., Nu, W., Cai, L., Hertz, L., & Peng, L. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1306-5 · Cited by 109
Driving GDNF expression: The green and the red traffic lights
Saavedra, A., Baltazar, G., & Duarte, E. P. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.09.006 · Cited by 106
Inhibition of astroglial Kir4.1 channels by selective serotonin reuptake inhibitors
Ohno, Y., Hibino, H., Lossin, C., Inanobe, A., & Kurachi, Y. (2007) · Brain Research · doi:10.1016/j.brainres.2007.08.018 · Cited by 105
Fluoxetine rescues impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse model
Kohl, Z., Winner, B., Ubhi, K., Rockenstein, E., Mante, M., Münch, M., Barlow, C., Carter, T., Masliah, E., & Winkler, J. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07933.x · Cited by 101
Therapeutic Potential of Fluoxetine in Neurological Disorders
Mostert, J. P., Koch, M. W., Heerings, M. A. P., Heersema, D. J., & Keyser, J. D. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1527-3458.2008.00040.x · Cited by 102
Mostert, J. P., Behloul, F., Hoogduin, J. M., Luyendijk, J. M., Heersema, D. J., van Buchem, M. A., & Keyser, J. D. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.139345 · Cited by 100
Qi, D., Ouyang, C., Wang, Y., Zhang, S., Ma, X., Song, Y., Yu, H., Tang, J., Fu, W. E., Sheng, L., et al. (2014) · Brain Research · doi:10.1016/j.brainres.2014.06.031 · Cited by 94
Neuroplasticity and the next wave of antidepressant strategies
Hayley, S., & Litteljohn, D. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00218 · Cited by 92
Drzyzga, Ł. R., Marcinowska, A., & Obuchowicz, E. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.03.009 · Cited by 90
Effect of treatment on serum glial cell line-derived neurotrophic factor in depressed patients
Zhang, X., Zhang, Z., Xie, C., Xi, G., Zhou, H., Zhang, Y., & Sha, W. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.01.004 · Cited by 88
Kipp, M., Karakaya, S., Pawlak, J., de Araújo, G. W., Arnold, S., & Beyer, C. (2006) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2006.07.001 · Cited by 85
Ubhi, K. K., Inglis, C. A., Mante, M., Patrick, C., Adame, A., Spencer, B. J., Rockenstein, E. M., May, V. E. L., Winkler, J., & Masliah, E. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.01.008 · Cited by 87
Kajitani, N., Hisaoka‐Nakashima, K., Morioka, N., Okada‐Tsuchioka, M., Kaneko, M., Kasai, M., Shibasaki, C., Nakata, Y., & Takebayashi, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051197 · Cited by 87
5-HT2 ligands in the treatment of anxiety and depression
Quesseveur, G., Nguyen, H. T., Gardier, A. M., & Guiard, B. P. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.719872 · Cited by 87
Future antidepressant targets: neurotrophic factors and related signaling cascades
Schmidt, H. D., Banasr, M., & Duman, R. S. (2008) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2008.10.003 · Cited by 87
Targeting astrocytes in major depression
Peng, L., Verkhratsky, A., Gu, L., & Li, B. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1095094 · Cited by 88
Martín-Hernández, D., Caso, J. R., Javier Meana, J., Callado, L. F., Madrigal, J. L. M., García-Bueno, B., & Leza, J. C. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1294-2 · Cited by 80
Diversiform Etiologies for Post-stroke Depression
Wang, Z., Shi, Y., Liu, F., Jia, N., Gao, J., Pang, X., & Deng, F. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00761 · Cited by 81
Đurić, V., & Duman, R. S. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1020-7 · Cited by 80
Michel, T. M., Frangou, S., Camara, S., Thiemeyer, D., Jecel, J., Tatschner, T., Zoechling, R., & Grünblatt, E. (2008) · European Psychiatry · doi:10.1016/j.eurpsy.2008.06.001 · Cited by 78
Marton, S., González, B., Rodríguez-Bottero, S., Miquel, E., Palma, L. M., Pazos, M., Prieto, J. P., Rodríguez, P., Sameš, D., Seoane, G. A., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00193 · Cited by 77
Chiou, S., Ku, H., Tsai, T., Lin, H., Chen, L., Chien, C., Ho, L. L. ‐., Lee, C., & Chang, Y. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706766 · Cited by 73
Huang, S. A., Mulcahey, M. A., Crescenzi, A., Chung, M., Kim, B. W., Barnes, C., Kuijt, W. J., Turano, H., Harney, J. W., & Larsen, P. R. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0173 · Cited by 74
Morioka, N., Suekama, K., Zhang, F. F., Kajitani, N., Hisaoka‐Nakashima, K., Takebayashi, M., & Nakata, Y. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12614 · Cited by 73
Hung, S., Liou, H., & Fu, W. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.11.003 · Cited by 73
Stepulak, A., Rzeski, W., Sifringer, M., Brocke, K. S., Gratopp, A., Kupisz, K., Turski, L., & Ikonomidou, C. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.10.6664 · Cited by 73
Huang, Y.-Y., Peng, C.-H., Yang, Y.-P., Wu, C.-C., Hsu, W., Wang, H.-J., Chan, K.-H., Chou, Y., Chen, S., & Chang, Y.-L. (2007) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0061255 · Cited by 66
Hertz, L., Rothman, D. L., Li, B., & Peng, L. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00025 · Cited by 66
Anderson, G., & Maes, M. H. J. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666140711091400 · Cited by 65
Intracellular signaling pathways pave roads to recovery for mood disorders
Tanis, K. Q., & Duman, R. S. (2007) · Annals of Medicine · doi:10.1080/07853890701483270 · Cited by 64
Epigenetics and Suicidal Behavior Research Pathways
Turecki, G. (2014) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2014.06.011 · Cited by 65
Ha, E., Jung, K. H., Choe, B., Bae, J., Shin, D.-H., Yim, S., & Baik, H. H. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.022 · Cited by 60
5-HTT independent effects of fluoxetine on neuroplasticity
Levy, M. J. F., Boulle, F., Emerit, M. B., Poilbout, C., Steinbusch, H. W. M., van den Hove, D., Kenis, G., & Lanfumey, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-42775-w · Cited by 59
Hisaoka, K., Tsuchioka, M., Yano, R., Maeda, N., Kajitani, N., Morioka, N., Nakata, Y., & Takebayashi, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.224683 · Cited by 57
Thyroid Hormone Deiodinases in the Central and Peripheral Nervous System
Courtin, F., Zrouri, H., Lamirand, A., Li, W. W., MERCIER, G., Schumacher, M., Goascogne, C. L., & Pierre, M. (2005) · Thyroid · doi:10.1089/thy.2005.15.931 · Cited by 56
Self-citationFluoxetine increases cerebral white matter NAA/Cr ratio in patients with multiple sclerosis
Mostert, J. P., Sijens, P. E., Oudkerk, M., & Keyser, J. D. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.03.042 · Cited by 56
Franco, J. L. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.11.012 · Cited by 57
Effect of treatment on serum glial cell line-derived neurotrophic factor in bipolar patients
Zhang, X., Zhang, Z., Sha, W., Xie, C., Xi, G., Zhou, H., & Zhang, Y. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.03.003 · Cited by 54
Astrocytic β2-adrenergic receptors: From physiology to pathology
Laureys, G., Clinckers, R., Gerlo, S., Spooren, A., Wilczak, N., Kooijman, R., Smolders, I. J., Michotte, Y. M., & Keyser, J. D. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.01.011 · Cited by 57
Golan, M., Schreiber, G., & Avissar, S. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001550 · Cited by 54
Zhang, X., Zhang, Z., Sha, W., Xie, C., Xi, G., Zhou, H., & Zhang, Y. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2009.01.011 · Cited by 55
Li, B., Zhang, S., Li, M., Hertz, L., & Peng, L. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1631-3 · Cited by 52
Nie, H., Peng, Z., Ning, L., Wang, H., Chen, Y., Fang, Z., Hou, W., Gao, F., Li, X., Xiong, L., et al. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.01.002 · Cited by 52
The Monoaminergic Tripartite Synapse: A Putative Target for Currently Available Antidepressant Drugs
Quesseveur, G., Gardier, A. M., & Guiard, B. P. (2013) · Current Drug Targets · doi:10.2174/13894501113149990209 · Cited by 55
Nordenberg (2010) · International Journal of Oncology · doi:10.3892/ijo_00000756 · Cited by 49
Oxidative Stress Regulates Type 3 Deiodinase and Type 2 Deiodinase in Cultured Rat Astrocytes
Lamirand, A., Pallud, S. E., Ramaugé, M., Pierre, M., & Courtin, F. (2008) · Endocrinology · doi:10.1210/en.2007-1462 · Cited by 48
Self-citationAlmeida, R. C., Granato‐Souza, D., Soletti, R. C., López, M. G., Rodrigues, A. L. S., & Gabilan, N. H. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.10.057 · Cited by 49
Huang, W. C., Zhao, Y. C., Zhu, X., Cai, Z., Wang, S., Yao, S., Qi, Z., & Xie, P. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9822-5 · Cited by 47
Calati, R., Crisafulli, C., Balestri, M., Serretti, A., Spina, E., Calabrò, M., Sidoti, A., Albani, D., Massat, I., Höfer, P., et al. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.03.005 · Cited by 45
Tsybko, A. S., Ilchibaeva, T. V., & Popova, N. K. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0063 · Cited by 48
Villegas, S. N., Njaine, B., Linden, R., & Carri, N. G. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.08.014 · Cited by 44
Domin, H., Szewczyk, B., Woźniak, M., Wawrzak-Wleciał, A., & Śmiałowska, M. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.019 · Cited by 44
Lu, D., Leung, Y., & Su, K. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000338 · Cited by 43
Shadfar, S., Kim, Y.-G., Katila, N., Neupane, S., Ojha, U., Bhurtel, S., Srivastav, S., Jeong, G., Park, P., Hong, J. T., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0342-0 · Cited by 42
Lee, H., Rao, J. S., Ertley, R. N., Chang, L., Rapoport, S. I., & Bazinet, R. P. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0582-1 · Cited by 42
RetractedRao, J. S., Ertley, R. N., Lee, H.-J., Rapoport, S. I., & Bazinet, R. P. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500391 · Cited by 40
RetractedPrenatal SSRI exposure: Effects on later child development
Hermansen, T. K., & Melinder, A. (2015) · Child Neuropsychology · doi:10.1080/09297049.2014.942727 · Cited by 38
Signaling mechanisms involved in the acute effects of estradiol on 5-HT clearance
Benmansour, S., Privratsky, A. A., Adeniji, O. S., & Frazer, A. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571300165x · Cited by 38
Ruban, A., Avissar, S., & Schreiber, G. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.08.007 · Cited by 38
The role of MAP kinases in rapid gene induction after lesioning of the rat sciatic nerve
Zrouri, H., Goascogne, C. L., Li, W. W., Pierre, M., & Courtin, F. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03641.x · Cited by 37
Self-citationAmit, B. H., Gil‐Ad, I., Taler, M., Bar, M., Zolokov, A., & Weizman, A. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.06.003 · Cited by 37
Daniele, S., Zappelli, E., & Martini, C. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0446-x · Cited by 36
Memory in astrocytes: a hypothesis
Caudle, R. M. (2006) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-3-2 · Cited by 37
Liu, X., Li, P., Ma, X., Zhang, J., Sun, X., Luo, X., & Zhang, Y. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.07.041 · Cited by 34
Neurobiological aspects of depressive disorder and antidepressant treatment: role of glia
Páv, M., Kovárů, H., Fišerová, A., Havrdová, E., & Lisá, V. (2008) · Physiological Research · doi:10.33549/physiolres.930990 · Cited by 34
Avissar, S., & Schreiber, G. (2005) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.11.003 · Cited by 35
Chilmończyk, Z., Bojarski, A. J., Pilc, A., & Sylte, I. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.01.011 · Cited by 31
Peng, Z., Zhang, R., Wang, H., Chen, Y., Xue, F., Wang, L., Yang, F., Chen, Y., Liu, L., Kuang, F., et al. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.01.032 · Cited by 30
Pawluski, J. L. (2011) · Neuroendocrinology · doi:10.1159/000329293 · Cited by 30
Fluoxetin upregulates connexin 43 expression in astrocyte.
Mostafavi, H., Khaksarian, M., Joghataei, M. T., Hassanzadeh, G., Soleimani, M., Eftekhari, S., Soleimani, M., Mousavizadeh, K., & Hadjighassem, M. (2014) · PubMed Central · Cited by 30
The Role of Neurotrophic Factors in Pathophysiology of Major Depressive Disorder
Amidfar, M., Réus, G. Z., de Moura, A. B., Quevedo, J., & Kim, Y. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6044-0_14 · Cited by 31
Satyanarayanan, S. K., Shih, Y.-H., Chien, Y.-C., Huang, S., Gałecki, P., Kasper, S. F., Chang, J. P., & Su, K. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0899-x · Cited by 28
Astrocytic transactivation by α2A-adrenergic and 5-HT2B serotonergic signaling
Peng, L., Li, B., Du, T., Kong, E. K. C., Hu, X., Zhang, S., Shan, X., & Zhang, M. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.04.018 · Cited by 32
Paumier, K. L., Sortwell, C. E., Madhavan, L., Terpstra, B. T., Daley, B. F., & Collier, T. J. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.02.005 · Cited by 28
Regulators of G-protein-coupled receptor–G-protein coupling: antidepressants mechanism of action
Schreiber, G., & Avissar, S. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.1.75 · Cited by 28
Antidepressants for neuroprotection in Huntington's disease: A review
Jamwal, S., & Kumar, P. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.10.033 · Cited by 27
Shi, Y., Yuan, Y., Xu, Z., Pu, M., Wang, C., Zhang, Y., Liu, Z., Wang, C., Li, L., & Zhang, Z. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.10.030 · Cited by 26
Cunha, M. P., Budni, J., Pazini, F. L., Oliveira‐Giacomelli, Á., Rosa, J. M., Lopes, M. W., Leal, R. B., & Rodrigues, A. L. S. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.03.004 · Cited by 26
Ramos-Hryb, A. B., Cunha, M. P., Pazini, F. L., Lieberknecht, V., Prediger, R. D., Kaster, M. P., & Rodrigues, A. L. S. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.05.009 · Cited by 26
β-Arrestin signaling complex as a target for antidepressants and as a depression marker
Schreiber, G., Golan, M., & Avissar, S. (2009) · Drug News & Perspectives · doi:10.1358/dnp.2009.22.8.1413787 · Cited by 27
Olianas, M. C., Dedoni, S., & Onali, P. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.236455 · Cited by 24
Metadata
- Authors
- Mercier, G., Lennon, A. M., Renouf, B., Dessouroux, A., Ramaugé, M., Courtin, F., & Pierre, M.
- Affiliations
- Inserm (FR)
- Corresponding author
- Mercier, Gilles
- Venue
- Journal of Molecular Neuroscience
- Published
- 2004
- Volume
- 24
- Issue
- 2
- Pages
- 207-216
- ISSN
- 0895-8696 (ISSN-L)
- OpenAlex
- W1996567906
- Cited by
- 176
- References
- 47
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 1 · 2023: 5 · 2022: 1 · 2021: 4 · 2020: 1 · 2019: 6 · 2018: 6 · 2017: 8 · 2016: 6 · 2015: 10 · 2014: 19 · 2013: 11 · 2012: 14
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Molecular Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- fluoxetine, astrocytes, MAPK signaling, ERK, p38 MAPK, antidepressants, neuroprotection, brain-derived neurotrophic factor, glial cell line-derived neurotrophic factor, gene expression, major depressive disorder, U0126, SB203580
- MeSH terms
- Animals, Astrocytes, Cells, Cultured, Enzyme Activation, Fluoxetine, Gene Expression Regulation, Nerve Growth Factors, Nerve Tissue Proteins, Proto-Oncogene Proteins, Signal Transduction, Transcriptional Activation, Rats, Sprague-Dawley, Protein Serine-Threonine Kinases, Antidepressive Agents, Second-Generation, Brain-Derived Neurotrophic Factor, Receptor, trkB, Mitogen-Activated Protein Kinases, Extracellular Signal-Regulated MAP Kinases, p38 Mitogen-Activated Protein Kinases, Proto-Oncogene Proteins c-akt, Glial Cell Line-Derived Neurotrophic Factor, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review